Regulation of inflammation by interleukin-4: A review of "alternatives"

Journal of Leukocyte Biology

Volumn 92, Issue 4, 2012, Pages 753-764

  Luzina, Irina G ^a,b   Keegan, Achsah D ^a   Heller, Nicola M ^c   Rook, Graham A W ^d   Shea Donohue, Terez ^a   Atamas, Sergei P ^a,b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b BALTIMORE VA MEDICAL CENTER   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Alternative macrophage activation; Alternative splicing; Interelukin 4 receptor; Interleukin 4 signaling

Indexed keywords

CYTOKINE; INTERLEUKIN 13 RECEPTOR; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR; INTERLEUKIN 4DELTA2; MESSENGER RNA; UNCLASSIFIED DRUG;

ASTHMA; CELL DIFFERENTIATION; GENETIC VARIABILITY; HUMAN; IMMUNOREGULATION; MACROPHAGE ACTIVATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; RNA SPLICING; SCLERODERMA; SIGNAL TRANSDUCTION; TUBERCULOSIS;

ANIMALS; ASTHMA; HUMANS; INFLAMMATION; INTERLEUKIN-4; MACROPHAGE ACTIVATION; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 6; RECEPTORS, INTERLEUKIN-13; RECEPTORS, INTERLEUKIN-4; SCLERODERMA, SYSTEMIC; SIGNAL TRANSDUCTION; TUBERCULOSIS;

EID: 84867908227     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.0412214     Document Type: Review

References (178)

1. Nelms, K., Keegan, A. D., Zamorano, J., Ryan, J. J., Paul, W. E. (1999) The IL-4 receptor: signaling mechanisms and biologic functions. Annu. Rev. Immunol. 17, 701-738.
2. Kelly-Welch, A., Hanson, E. M., Keegan, A. D. (2005) Interleukin-13 (IL-13) pathway. Sci. STKE 2005, cm8.
3. Mueller, T. D., Zhang, J. L., Sebald, W., Duschl, A. (2002) Structure, binding, and antagonists in the IL-4/IL-13 receptor system. Biochim. Biophys. Acta 1592, 237-250.
4. Chomarat, P., Banchereau, J. (1998) Interleukin-4 and interleukin-13: their similarities and discrepancies. Int. Rev. Immunol. 17, 1-52.
5. Murata, T., Obiri, N. I., Puri, R. K. (1998) Structure of and signal transduction through interleukin-4 and interleukin-13 receptors (review). Int. J. Mol. Med. 1, 551-557.
6. Kelly-Welch, A. E., Hanson, E. M., Boothby, M. R., Keegan, A. D. (2003) Interleukin-4 and interleukin-13 signaling connections maps. Science 300, 1527-1528.
7. LaPorte, S. L., Juo, Z. S., Vaclavikova, J., Colf, L. A., Qi, X., Heller, N. M., Keegan, A. D., Garcia, K. C. (2008) Molecular and structural basis of cytokine receptor pleiotropy in the interleukin-4/13 system. Cell 132, 259-272.
8. Iseki, M., Omori-Miyake, M., Xu, W., Sun, X., Takaki, S., Rawlings, D. J., Ziegler, S. F. (2012) Thymic stromal lymphopoietin (TSLP)-induced polyclonal B-cell activation and autoimmunity are mediated by CD4+ T cells and IL-4. Int. Immunol. 24, 183-195.
9. Okayama, Y., Okumura, S., Sagara, H., Yuki, K., Sasaki, T., Watanabe, N., Fueki, M., Sugiyama, K., Takeda, K., Fukuda, T., Saito, H., Ra, C. (2009) FcIe{cyrillic, ukrainian}RI-mediated thymic stromal lymphopoietin production by interleukin-4-primed human mast cells. Eur. Respir. J. 34, 425-435.
10. Omori, M., Ziegler, S. (2007) Induction of IL-4 expression in CD4(+) T cells by thymic stromal lymphopoietin. J. Immunol. 178, 1396-1404.
11. Schmitz, J., Owyang, A., Oldham, E., Song, Y., Murphy, E., McClanahan, T. K., Zurawski, G., Moshrefi, M., Qin, J., Li, X., Gorman, D. M., Bazan, J. F., Kastelein, R. A. (2005) IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23, 479-490.
12. Frohlich, A., Marsland, B. J., Sonderegger, I., Kurrer, M., Hodge, M. R., Harris, N. L., Kopf, M. (2007) IL-21 receptor signaling is integral to the development of Th2 effector responses in vivo. Blood 109, 2023-2031.
13. Angkasekwinai, P., Park, H., Wang, Y. H., Chang, S. H., Corry, D. B., Liu, Y. J., Zhu, Z., Dong, C. (2007) Interleukin 25 promotes the initiation of proallergic type 2 responses. J. Exp. Med. 204, 1509-1517.
14. Zhu, J., Paul, W. E. (2008) CD4 T cells: fates, functions, and faults. Blood 112, 1557-1569.
15. Constant, S. L., Bottomly, K. (1997) Induction of Th1 and Th2 CD4+ T cell responses: the alternative approaches. Annu. Rev. Immunol. 15, 297-322.
16. Bi, Y., Liu, G., Yang, R. (2011) Reciprocal modulation between TH17 and other helper T cell lineages. J. Cell. Physiol. 226, 8-13.
17. Otsuka, T., Villaret, D., Yokota, T., Takebe, Y., Lee, F., Arai, N., Arai, K. (1987) Structural analysis of the mouse chromosomal gene encoding interleukin 4 which expresses B cell, T cell and mast cell stimulating activities. Nucleic Acids Res. 15, 333-344.
18. Arai, N., Nomura, D., Villaret, D., DeWaal Malefijt, R., Seiki, M., Yoshida, M., Minoshima, S., Fukuyama, R., Maekawa, M., Kudoh, J. (1989) Complete nucleotide sequence of the chromosomal gene for human IL-4 and its expression. J. Immunol. 142, 274-282.
19. Alms, W. J., Atamas, S. P., Yurovsky, V. V., White, B. (1996) Generation of a variant of human interleukin-4 by alternative splicing. Mol. Immunol. 33, 361-370.
20. Atamas, S. P., Choi, J., Yurovsky, V. V., White, B. (1996) An alternative splice variant of human IL-4, IL-4 δ 2, inhibits IL-4-stimulated T cell proliferation. J. Immunol. 156, 435-441.
21. Arinobu, Y., Atamas, S. P., Otsuka, T., Niiro, H., Yamaoka, K., Mitsuyasu, H., Niho, Y., Hamasaki, N., White, B., Izuhara, K. (1999) Antagonistic effects of an alternative splice variant of human IL-4, IL-4δ2, on IL-4 activities in human monocytes and B cells. Cell. Immunol. 191, 161-167.
22. Zav'yalov, V. P., Denesyuk, A. I., White, B., Yurovsky, V. V., Atamas, S. P., Korpela, T. (1997) Molecular model of an alternative splice variant of human IL-4, IL-4 δ 2, a naturally occurring inhibitor of IL-4-stimulated T cell proliferation. Immunol. Lett. 58, 149-152.
23. Rhodes, S. G., Sawyer, J., Whelan, A. O., Dean, G. S., Coad, M., Ewer, K. J., Waldvogel, A. S., Zakher, A., Clifford, D. J., Hewinson, R. G., Vordermeier, H. M. (2007) Is interleukin-4δ3 splice variant expression in bovine tuberculosis a marker of protective immunity? Infect. Immun. 75, 3006-3013.
24. Yuan, Z., Wang, R., Lee, Y., Chen, C. Y., Yu, X., Wu, Z., Huang, D., Shen, L., Chen, Z. W. (2009) Tuberculosis-induced variant IL-4 mRNA encodes a cytokine functioning as growth factor for (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate-specific Vγ2Vδ2 T cells. J. Immunol. 182, 811-819.
25. Gautherot, I., Burdin, N., Seguin, D., Aujame, L., Sodoyer, R. (2002) Cloning of interleukin-4 δ2 splice variant (IL-4δ2) in chimpanzee and cynomolgus macaque: phylogenetic analysis of δ2 splice variant appearance, and implications for the study of IL-4-driven immune processes. Immunogenetics 54, 635-644.
26. Waldvogel, A. S., Lepage, M. F., Zakher, A., Reichel, M. P., Eicher, R., Heussler, V. T. (2004) Expression of interleukin 4, interleukin 4 splice variants and interferon γ mRNA in calves experimentally infected with Fasciola hepatica. Vet. Immunol. Immunopathol. 97, 53-63.
27. Yatsenko, O. P., Filipenko, M. L., Khrapov, E. A., Voronina, E. N., Kozlov, V. A., Sennikov, S. V. (2004) Alternative splicing of mRNA of mouse interleukin-4 and interleukin-6. Cytokine 28, 190-196.
28. Luzina, I. G., Lockatell, V., Todd, N. W., Highsmith, K., Keegan, A. D., Hasday, J. D., Atamas, S. P. (2011) Alternatively spliced variants of interleukin-4 promote inflammation differentially. J. Leukoc. Biol. 89, 763-770.
29. Luzina, I. G., Lockatell, V., Todd, N. W., Keegan, A. D., Hasday, J. D., Atamas, S. P. (2011) Splice isoforms of human interleukin-4 are functionally active in mice in vivo. Immunology 132, 385-393.
30. De Moraes-Pinto, M. I., Vince, G. S., Flanagan, B. F., Hart, C. A., Johnson, P. M. (1997) Localization of IL-4 and IL-4 receptors in the human term placenta, decidua and amniochorionic membranes. Immunology 90, 87-94.
31. Orsini, B., Vivas, J. R., Ottanelli, B., Amedei, A., Surrenti, E., Galli, A., Milani, S., Pinzani, P., Del Prete, G., Surrenti, C., Baldari, C. T., Touati, E., D'Elios, M. M. (2007) Human gastric epithelium produces IL-4 and IL-4δ2 isoform only upon Helicobacter pylori infection. Int. J. Immunopathol. Pharmacol. 20, 809-818.
32. Orsini, B., Ottanelli, B., Amedei, A., Surrenti, E., Capanni, M., Del Prete, G., Amorosi, A., Milani, S., D'Elios, M. M., Surrenti, C. (2003) Helicobacter pylori cag pathogenicity island is associated with reduced expression of interleukin-4 (IL-4) mRNA and modulation of the IL-4δ2 mRNA isoform in human gastric mucosa. Infect. Immun. 71, 6664-6667.
33. Pouliot, P., Turmel, V., Gelinas, E., Laviolette, M., Bissonnette, E. Y. (2005) Interleukin-4 production by human alveolar macrophages. Clin. Exp. Allergy 35, 804-810.
34. Plante, S., Semlali, A., Joubert, P., Bissonnette, E., Laviolette, M., Hamid, Q., Chakir, J. (2006) Mast cells regulate procollagen I (α 1) production by bronchial fibroblasts derived from subjects with asthma through IL-4/IL-4 δ 2 ratio. J. Allergy Clin. Immunol. 117, 1321-1327.
35. Glare, E. M., Divjak, M., Rolland, J. M., Walters, E. H. (1999) Asthmatic airway biopsy specimens are more likely to express the IL-4 alternative splice variant IL-4δ2. J. Allergy Clin. Immunol. 104, 978-982.
36. Seah, G. T., Gao, P. S., Hopkin, J. M., Rook, G. A. (2001) Interleukin-4 and its alternatively spliced variant (IL-4δ2) in patients with atopic asthma. Am. J. Respir. Crit. Care Med. 164, 1016-1018.
37. Glare, E. M., Divjak, M., Bailey, M. J., Walters, E. H. (2001) The usefulness of competitive PCR: airway gene expression of IL-5, IL-4, IL-4δ2, IL-2, and IFNγ in asthma. Thorax 56, 541-548.
38. Luzina, I. G., Lockatell, V., Lavania, S., Pickering, E. M., Kang, P. H., Bashkatova, Y. N., Andreev, S. M., Atamas, S. P. (2012) Natural production and functional effects of alternatively spliced interleukin-4 protein in asthma. Cytokine 58, 20-26.
39. Wu, H. P., Wu, C. L., Chen, C. K., Chung, K., Tseng, J. C., Liu, Y. C., Chuang, D. Y. (2008) The interleukin-4 expression in patients with severe sepsis. J. Crit. Care 23, 519-524.
40. Atamas, S. P., Yurovsky, V. V., Wise, R., Wigley, F. M., Goter Robinson, C. J., Henry, P., Alms, W. J., White, B. (1999) Production of type 2 cytokines by CD8+ lung cells is associated with greater decline in pulmonary function in patients with systemic sclerosis. Arthritis Rheum. 42, 1168-1178.
41. Sakkas, L. I., Tourtellotte, C., Berney, S., Myers, A. R., Platsoucas, C. D. (1999) Increased levels of alternatively spliced interleukin 4 (IL-4δ2) transcripts in peripheral blood mononuclear cells from patients with systemic sclerosis. Clin. Diagn. Lab. Immunol. 6, 660-664.
42. Atamas, S. P., White, B. (1999) Interleukin 4 in systemic sclerosis: not just an increase. Clin. Diagn. Lab. Immunol. 6, 658-659.
43. Seah, G. T., Rook, G. A. (1999) A sensitive, non-radioactive quantitative method for measuring IL-4 and IL-4δ2 mRNA in unstimulated cells from multiple clinical samples, using nested RT-PCR. J. Immunol. Methods 228, 139-149.
44. Seah, G. T., Scott, G. M., Rook, G. A. (2000) Type 2 cytokine gene activation and its relationship to extent of disease in patients with tuberculosis. J. Infect. Dis. 181, 385-389.
45. Dheda, K., Chang, J. S., Breen, R. A., Haddock, J. A., Lipman, M. C., Kim, L. U., Huggett, J. F., Johnson, M. A., Rook, G. A., Zumla, A. (2005) Expression of a novel cytokine, IL-4δ2, in HIV and HIV-tuberculosis co-infection. AIDS 19, 1601-1606.
46. Dheda, K., Chang, J. S., Breen, R. A., Kim, L. U., Haddock, J. A., Huggett, J. F., Johnson, M. A., Rook, G. A., Zumla, A. (2005) In vivo and in vitro studies of a novel cytokine, interleukin 4δ2, in pulmonary tuberculosis. Am. J. Respir. Crit. Care Med. 172, 501-508.
47. Djoba Siawaya, J. F., Bapela, N. B., Ronacher, K., Beyers, N., van Helden, P., Walzl, G. (2008) Differential expression of IL-4 and IL-4 δ2, but not transforming growth factor β (TGF-β), TGF-β RII, Foxp3, γ interferon, T-bet, or GATA-3 mRNA, in patients with fast and slow responders to antituberculosis treatment. Clin. Vaccine Immunol. 15, 1165-1170.
48. Demissie, A., Abebe, M., Aseffa, A., Rook, G., Fletcher, H., Zumla, A., Weldingh, K., Brock, I., Andersen, P., Doherty, T. M., VACSEL Study Group (2004) Healthy individuals that control a latent infection with M. tuberculosis express high levels of Th-1 cytokines and the IL-4 antagonist IL-4δ2. J. Immunol. 172, 6938-6943.
49. Fletcher, H. A., Owiafe, P., Jeffries, D., Hill, P., Rook, G. A. W., Zumla, A., Doherty, T. M., Brookes, R., VACSEL Study Group (2004) Increased expression of mRNA encoding IL-4 and its splice variant IL-4γ2 in cells from contacts of Mycobacterium tuberculosis in the absence of in vitro stimulation. Immunology 112, 669-673.
50. Mendez, A., Hernandez-Pando, R., Contreras, S., Aguilar, D., Rook, G. A. (2011) CCL2, CCL18 and sIL-4R in renal, meningeal and pulmonary TB; a 2 year study of patients and contacts. Tuberculosis (Edinb) 91, 140-145.
51. Demissie, A., Leyten, E. M., Abebe, M., Wassie, L., Aseffa, A., Abate, G., Fletcher, H., Owiafe, P., Hill, P. C., Brookes, R., Rook, G., Zumla, A., Arend, S. M., Klein, M., Ottenhoff, T. H., Andersen, P., Doherty, T. M., VACSEL Study Group (2006) Recognition of stage-specific mycobacterial antigens differentiates between acute and latent infections with Mycobacterium tuberculosis. Clin. Vaccine Immunol. 13, 179-186.
52. Ohara, J., Coligan, J. E., Zoon, K., Maloy, W. L., Paul, W. E. (1987) High-efficiency purification and chemical characterization of B cell stimulatory factor-1/interleukin 4. J. Immunol. 139, 1127-1134.
53. Park, L. S., Friend, D., Grabstein, K., Urdal, D. L. (1987) Characterization of the high-affinity cell-surface receptor for murine B-cell-stimulating factor 1. Proc. Natl. Acad. Sci. USA 84, 1669-1673.
54. Lowenthal, J. W., Castle, B. E., Christiansen, J., Schreurs, J., Rennick, D., Arai, N., Hoy, P., Takebe, Y., Howard, M. (1988) Expression of high affinity receptors for murine interleukin 4 (BSF-1) on hemopoietic and nonhemopoietic cells. J. Immunol. 140, 456-464.
55. Russell, S. M., Keegan, A. D., Harada, N., Nakamura, Y., Noguchi, M., Leland, P., Friedmann, M. C., Miyajima, A., Puri, R. K., Paul, W. E. (1993) Interleukin-2 receptor γ chain: a functional component of the interleukin-4 receptor. Science 262, 1880-1883.
56. Kondo, M., Takeshita, T., Ishii, N., Nakamura, M., Watanabe, S., Arai, K., Sugamura, K. (1993) Sharing of the interleukin-2 (IL-2) receptor γ chain between receptors for IL-2 and IL-4. Science 262, 1874-1877.
57. Takeshita, T., Asao, H., Ohtani, K., Ishii, N., Kumaki, S., Tanaka, N., Munakata, H., Nakamura, M., Sugamura, K. (1992) Cloning of the γ chain of the human IL-2 receptor. Science 257, 379-382.
58. Cao, X., Kozak, C. A., Liu, Y. J., Noguchi, M., O'Connell, E., Leonard, W. J. (1993) Characterization of cDNAs encoding the murine interleukin 2 receptor (IL-2R) γ chain: chromosomal mapping and tissue specificity of IL-2R γ chain expression. Proc. Natl. Acad. Sci. USA 90, 8464-8468.
59. Letzelter, F., Wang, Y., Sebald, W. (1998) The interleukin-4 site-2 epitope determining binding of the common receptor γ chain. Eur. J. Biochem. 257, 11-20.
60. Lesur, O., Arsalane, K., Berard, J., Mukuna, J. P., de Brum-Fernandes, A. J., Lane, D., Rola-Pleszczynski, M. (1997) Functional IL-2 receptors are expressed by rat lung type II epithelial cells. Am. J. Physiol. 273, L495-L503.
61. Van der Velden, V. H., Naber, B. A., Wierenga-Wolf, A. F., Debets, R., Savelkoul, H. F., Overbeek, S. E., Hoogsteden, H. C., Versnel, M. A. (1998) Interleukin 4 receptors on human bronchial epithelial cells. An in vivo and in vitro analysis of expression and function. Cytokine 10, 803-813.
62. Yamamoto, S., Kobayashi, I., Tsuji, K., Nishi, N., Muro, E., Miyazaki, M., Zaitsu, M., Inada, S., Ichimaru, T., Hamasaki, Y. (2004) Upregulation of interleukin-4 receptor by interferon-γ: enhanced interleukin-4-induced eotaxin-3 production in airway epithelium. Am. J. Respir. Cell Mol. Biol. 31, 456-462.
63. Obiri, N. I., Debinski, W., Leonard, W. J., Puri, R. K. (1995) Receptor for interleukin 13. Interaction with interleukin 4 by a mechanism that does not involve the common γ chain shared by receptors for interleukins 2, 4, 7, 9, and 15. J. Biol. Chem. 270, 8797-8804.
64. Hilton, D. J., Zhang, J. G., Metcalf, D., Alexander, W. S., Nicola, N. A., Willson, T. A. (1996) Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptor. Proc. Natl. Acad. Sci. USA 93, 497-501.
65. Miloux, B., Laurent, P., Bonnin, O., Lupker, J., Caput, D., Vita, N., Ferrara, P. (1997) Cloning of the human IL-13R α1 chain and reconstitution with the IL4R α of a functional IL-4/IL-13 receptor complex. FEBS Lett. 401, 163-166.
66. Donaldson, D. D., Whitters, M. J., Fitz, L. J., Neben, T. Y., Finnerty, H., Henderson, S. L., O'Hara R. M., Jr., Beier, D. R., Turner, K. J., Wood, C. R. (1998) The murine IL-13 receptor α 2: molecular cloning, characterization, and comparison with murine IL-13 receptor α 1. J. Immunol. 161, 2317-2324.
67. Kawakami, K., Taguchi, J., Murata, T., Puri, R. K. (2001) The interleukin-13 receptor α2 chain: an essential component for binding and internalization but not for interleukin-13-induced signal transduction through the STAT6 pathway. Blood 97, 2673-2679.
68. Zhang, J. G., Hilton, D. J., Willson, T. A., McFarlane, C., Roberts, B. A., Moritz, R. L., Simpson, R. J., Alexander, W. S., Metcalf, D., Nicola, N. A. (1997) Identification, purification, and characterization of a soluble interleukin (IL)-13-binding protein. Evidence that it is distinct from the cloned Il-13 receptor and Il-4 receptor α-chains. J. Biol. Chem. 272, 9474-9480.
69. Wood, N., Whitters, M. J., Jacobson, B. A., Witek, J., Sypek, J. P., Kasaian, M., Eppihimer, M. J., Unger, M., Tanaka, T., Goldman, S. J. (2003) Enhanced interleukin (IL)-13 responses in mice lacking IL-13 receptor α 2. J. Exp. Med. 197, 703-709.
70. Fichtner-Feigl, S., Strober, W., Kawakami, K., Puri, R. K., Kitani, A. (2006) IL-13 signaling through the IL-13α2 receptor is involved in induction of TGF-β1 production and fibrosis. Nat. Med. 12, 99-106.
71. Schindler, C., Levy, D. E., Decker, T. (2007) JAK-STAT signaling: from interferons to cytokines. J. Biol. Chem. 282, 20059-20063.
72. Izuhara, K., Feldman, R. A., Greer, P., Harada, N. (1994) Interaction of the c-fes proto-oncogene product with the interleukin-4 receptor. J. Biol. Chem. 269, 18623-18629.
73. Ennaciri, J., Girard, D. (2009) IL-4R(+), a new member that associates with Syk kinase: implication in IL-4-induced human neutrophil functions. J. Immunol. 183, 5261-5269.
74. Kurzer, J. H., Argetsinger, L. S., Zhou, Y. J., Kouadio, J. L., O'Shea, J. J., Carter-Su, C. (2004) Tyrosine 813 is a site of JAK2 autophosphorylation critical for activation of JAK2 by SH2-B β. Mol. Cell. Biol. 24, 4557-4570.
75. Argetsinger, L. S., Kouadio, J. L., Steen, H., Stensballe, A., Jensen, O. N., Carter-Su, C. (2004) Autophosphorylation of JAK2 on tyrosines 221 and 570 regulates its activity. Mol. Cell. Biol. 24, 4955-4967.
76. Zhou, Y. J., Hanson, E. P., Chen, Y. Q., Magnuson, K., Chen, M., Swann, P. G., Wange, R. L., Changelian, P. S., O'Shea, J. J. (1997) Distinct tyrosine phosphorylation sites in JAK3 kinase domain positively and negatively regulate its enzymatic activity. Proc. Natl. Acad. Sci. USA 94, 13850-13855.
77. Liu, K. D., Gaffen, S. L., Goldsmith, M. A., Greene, W. C. (1997) Janus kinases in interleukin-2-mediated signaling: JAK1 and JAK3 are differentially regulated by tyrosine phosphorylation. Curr. Biol. 7, 817-826.
78. Wang, R., Griffin, P. R., Small, E. C., Thompson, J. E. (2003) Mechanism of Janus kinase 3-catalyzed phosphorylation of a Janus kinase 1 activation loop peptide. Arch. Biochem. Biophys. 410, 7-15.
79. Fujii, H. (2008) Receptor expression is essential for proliferation induced by dimerized Jak kinases. Biochem. Biophys. Res. Commun. 370, 557-560.
80. Wang, L. M., Keegan, A. D., Paul, W. E., Heidaran, M. A., Gutkind, J. S., Pierce, J. H. (1992) IL-4 activates a distinct signal transduction cascade from IL-3 in factor-dependent myeloid cells. EMBO J. 11, 4899-4908.
81. Smerz-Bertling, C., Duschl, A. (1995) Both interleukin 4 and interleukin 13 induce tyrosine phosphorylation of the 140-kDa subunit of the interleukin 4 receptor. J. Biol. Chem. 270, 966-970.
82. Orchansky, P. L., Kwan, R., Lee, F., Schrader, J. W. (1999) Characterization of the cytoplasmic domain of interleukin-13 receptor-β. J. Biol. Chem. 274, 20818-20825.
83. Umeshita-Suyama, R., Sugimoto, R., Akaiwa, M., Arima, K., Yu, B., Wada, M., Kuwano, M., Nakajima, K., Hamasaki, N., Izuhara, K. (2000) Characterization of IL-4 and IL-13 signals dependent on the human IL-13 receptor β chain 1: redundancy of requirement of tyrosine residue for STAT3 activation. Int. Immunol. 12, 1499-1509.
84. Koettnitz, K., Kalthoff, F. S. (1993) Human interleukin-4 receptor signaling requires sequences contained within two cytoplasmic regions. Eur. J. Immunol. 23, 988-991.
85. Seldin, D. C., Leder, P. (1994) Mutational analysis of a critical signaling domain of the human interleukin 4 receptor. Proc. Natl. Acad. Sci. USA 91, 2140-2144.
86. Keegan, A. D., Nelms, K., White, M., Wang, L. M., Pierce, J. H., Paul, W. E. (1994) An IL-4 receptor region containing an insulin receptor motif is important for IL-4-mediated IRS-1 phosphorylation and cell growth. Cell 76, 811-820.
87. Deutsch, H. H., Koettnitz, K., Chung, J., Kalthoff, F. S. (1995) Distinct sequence motifs within the cytoplasmic domain of the human IL-4 re-ceptor differentially regulate apoptosis inhibition and cell growth. J. Immunol. 154, 3696-3703.
88. Wang, H. Y., Paul, W. E., Keegan, A. D. (1996) IL-4 function can be transferred to the IL-2 receptor by tyrosine containing sequences found in the IL-4 receptor α chain. Immunity 4, 113-121.
89. Sun, X. J., Wang, L. M., Zhang, Y., Yenush, L., Myers M. G., Jr., Glasheen, E., Lane, W. S., Pierce, J. H., White, M. F. (1995) Role of IRS-2 in insulin and cytokine signalling. Nature 377, 173-177.
90. Zick, Y. (2005) Ser/Thr phosphorylation of IRS proteins: a molecular basis for insulin resistance. Sci. STKE 2005, pe4.
91. Heller, N. M., Qi, X., Junttila, I. S., Shirey, K. A., Vogel, S. N., Paul, W. E., Keegan, A. D. (2008) Type I IL-4Rs selectively activate IRS-2 to induce target gene expression in macrophages. Sci. Signal. 1, ra17.
92. Zamorano, J., Wang, H. Y., Wang, L. M., Pierce, J. H., Keegan, A. D. (1996) IL-4 protects cells from apoptosis via the insulin receptor substrate pathway and a second independent signaling pathway. J. Immunol. 157, 4926-4934.
93. Burks, D. J., Font de Mora, J., Schubert, M., Withers, D. J., Myers, M. G., Towery, H. H., Altamuro, S. L., Flint, C. L., White, M. F. (2000) IRS-2 pathways integrate female reproduction and energy homeostasis. Nature 407, 377-382.
94. Withers, D. J., Gutierrez, J. S., Towery, H., Burks, D. J., Ren, J. M., Previs, S., Zhang, Y., Bernal, D., Pons, S., Shulman, G. I. (1998) Disruption of IRS-2 causes type 2 diabetes in mice. Nature 391, 900-904.
95. Lee, H. M., Jin, H. S., Park, J. W., Park, S. M., Jeon, H. K., Lee, T. H. (2003) IL-4 augments anisomycin-induced p38 activation via Akt pathway in a follicular dendritic cell (FDC)-like line. FEBS Lett. 549, 110-114.
96. Hou, J., Schindler, U., Henzel, W. J., Ho, T. C., Brasseur, M., McKnight, S. L. (1994) An interleukin-4-induced transcription factor: IL-4 Stat. Science 265, 1701-1706.
97. Mikita, T., Campbell, D., Wu, P., Williamson, K., Schindler, U. (1996) Requirements for interleukin-4-induced gene expression and functional characterization of Stat6. Mol. Cell. Biol. 16, 5811-5820.
98. Schindler, U., Wu, P., Rothe, M., Brasseur, M., McKnight, S. L. (1995) Components of a Stat recognition code: evidence for two layers of molecular selectivity. Immunity 2, 689-697.
99. Shankaranarayanan, P., Chaitidis, P., Kuhn, H., Nigam, S. (2001) Acetylation by histone acetyltransferase CREB-binding protein/p300 of STAT6 is required for transcriptional activation of the 15-lipoxygenase-1 gene. J. Biol. Chem. 276, 42753-42760.
100. Chen, W., Daines, M. O., Hershey, G. K. (2004) Methylation of STAT6 modulates STAT6 phosphorylation, nuclear translocation, and DNAbinding activity. J. Immunol. 172, 6744-6750.
101. Pesu, M., Takaluoma, K., Aittomaki, S., Lagerstedt, A., Saksela, K., Kovanen, P. E., Silvennoinen, O. (2000) Interleukin-4-induced transcriptional activation by stat6 involves multiple serine/threonine kinase pathways and serine phosphorylation of Stat6. Blood 95, 494-502.
102. Wick, K. R., Berton, M. T. (2000) IL-4 induces serine phosphorylation of the STAT6 transactivation domain in B lymphocytes. Mol. Immunol. 37, 641-652.
103. Wang, Y., Malabarba, M. G., Nagy, Z. S., Kirken, R. A. (2004) Interleukin 4 regulates phosphorylation of serine 756 in the transactivation domain of Stat6. Roles for multiple phosphorylation sites and Stat6 function. J. Biol. Chem. 279, 25196-25203.
104. Shirakawa, T., Kawazoe, Y., Tsujikawa, T., Jung, D., Sato, S., Uesugi, M. (2011) Deactivation of STAT6 through serine 707 phosphorylation by JNK. J. Biol. Chem. 286, 4003-4010.
105. Pernis, A. B., Rothman, P. B. (2002) JAK-STAT signaling in asthma. J. Clin. Invest. 109, 1279-1283.
106. Ravetch, J. V., Lanier, L. L. (2000) Immune inhibitory receptors. Science 290, 84-89.
107. Zamorano, J., Keegan, A. D. (1998) Regulation of apoptosis by tyrosine-containing domains of IL-4R α: Y497 and Y713, but not the STAT6-docking tyrosines, signal protection from apoptosis. J. Immunol. 161, 859-867.
108. Imani, F., Rager, K. J., Catipovic, B., Marsh, D. G. (1997) Interleukin-4 (IL-4) induces phosphatidylinositol 3-kinase (p85) dephosphorylation. Implications for the role of SHP-1 in the IL-4-induced signals in human B cells. J. Biol. Chem. 272, 7927-7931.
109. Haque, S. J., Harbor, P., Tabrizi, M., Yi, T., Williams, B. R. (1998) Protein-tyrosine phosphatase Shp-1 is a negative regulator of IL-4-and IL-13-dependent signal transduction. J. Biol. Chem. 273, 33893-33896.
110. Lorenz, U. (2009) SHP-1 and SHP-2 in T cells: two phosphatases functioning at many levels. Immunol. Rev. 228, 342-359.
111. Hanson, E. M., Dickensheets, H., Qu, C. K., Donnelly, R. P., Keegan, A. D. (2003) Regulation of the dephosphorylation of Stat6. Participation of Tyr-713 in the interleukin-4 receptor α, the tyrosine phosphatase SHP-1, and the proteasome. J. Biol. Chem. 278, 3903-3911.
112. Yoshimura, A., Mori, H., Ohishi, M., Aki, D., Hanada, T. (2003) Negative regulation of cytokine signaling influences inflammation. Curr. Opin. Immunol. 15, 704-708.
113. Losman, J. A., Chen, X. P., Hilton, D., Rothman, P. (1999) Cutting edge: SOCS-1 is a potent inhibitor of IL-4 signal transduction. J. Immunol. 162, 3770-3774.
114. Haque, S. J., Harbor, P. C., Williams, B. R. (2000) Identification of critical residues required for suppressor of cytokine signaling-specific regulation of interleukin-4 signaling. J. Biol. Chem. 275, 26500-26506.
115. Yasukawa, H., Misawa, H., Sakamoto, H., Masuhara, M., Sasaki, A., Wakioka, T., Ohtsuka, S., Imaizumi, T., Matsuda, T., Ihle, J. N. (1999) The JAK-binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop. EMBO J. 18, 1309-1320.
116. Ram, P. A., Waxman, D. J. (1999) SOCS/CIS protein inhibition of growth hormone-stimulated STAT5 signaling by multiple mechanisms. J. Biol. Chem. 274, 35553-35561.
117. Monni, R., Santos, S. C., Mauchauffe, M., Berger, R., Ghysdael, J., Gouilleux, F., Gisselbrecht, S., Bernard, O., Penard-Lacronique, V. (2001) The TEL-Jak2 oncoprotein induces Socs1 expression and altered cytokine response in Ba/F3 cells. Oncogene 20, 849-858.
118. Frantsve, J., Schwaller, J., Sternberg, D. W., Kutok, J., Gilliland, D. G. (2001) Socs-1 inhibits TEL-JAK2-mediated transformation of hematopoietic cells through inhibition of JAK2 kinase activity and induction of proteasome-mediated degradation. Mol. Cell. Biol. 21, 3547-3557.
119. Wlodawer, A., Pavlovsky, A., Gustchina, A. (1992) Crystal structure of human recombinant interleukin-4 at 2.25 A resolution. FEBS Lett. 309, 59-64.
120. Mosmann, T. R., Yokota, T., Kastelein, R., Zurawski, S. M., Arai, N., Takebe, Y. (1987) Species-specificity of T cell stimulating activities of IL 2 and BSF-1 (IL 4): comparison of normal and recombinant, mouse and human IL 2 and BSF-1 (IL 4). J. Immunol. 138, 1813-1816.
121. Wang, Y., Shen, B. J., Sebald, W. (1997) A mixed-charge pair in human interleukin 4 dominates high-affinity interaction with the receptor α chain. Proc. Natl. Acad. Sci. USA 94, 1657-1662.
122. Baumhofer, J. M., Beinhauer, B. G., Wang, J. E., Brandmeier, H., Geissler, K., Losert, U., Philip, R., Aversa, G., Rogy, M. A. (1998) Gene transfer with IL-4 and IL-13 improves survival in lethal endotoxemia in the mouse and ameliorates peritoneal macrophages immune competence. Eur. J. Immunol. 28, 610-615.
123. Volpert, O. V., Fong, T., Koch, A. E., Peterson, J. D., Waltenbaugh, C., Tepper, R. I., Bouck, N. P. (1998) Inhibition of angiogenesis by interleukin 4. J. Exp. Med. 188, 1039-1046.
124. Stein, M., Keshav, S., Harris, N., Gordon, S. (1992) Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J. Exp. Med. 176, 287-292.
125. Chang Y-J, Kim, H. Y., Albacker, L. A., Baumgarth, N., McKenzie, A. N. J., Smith, D. E., DeKruyff, R. H., Umetsu, D. T. (2011) Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity. Nat. Immunol. 12, 631-638.
126. Kim, E. Y., Battaile, J. T., Patel, A. C., You, Y., Agapov, E., Grayson, M. H., Benoit, L. A., Byers, D. E., Alevy, Y., Tucker, J. (2008) Persistent activation of an innate immune response translates respiratory viral infection into chronic lung disease. Nat. Med. 14, 633-640.
127. Shirey, K. A., Cole, L. E., Keegan, A. D., Vogel, S. N. (2008) Francisella tularensis live vaccine strain induces macrophage alternative activation as a survival mechanism. J. Immunol. 181, 4159-4167.
128. Shirey, K. A., Pletneva, L. M., Puche, A. C., Keegan, A. D., Prince, G. A., Blanco, J. C. G., Vogel, S. N. (2010) Control of RSV-induced lung injury by alternatively activated macrophages is IL-4Rα-, TLR4-, and IFN-β-dependent. Mucosal Immunol. 3, 291-300.
129. Kodelja, V., Muller, C., Politz, O., Hakij, N., Orfanos, C. E., Goerdt, S. (1998) Alternative macrophage activation-associated CC-chemokine-1, a novel structural homologue of macrophage inflammatory protein-1 α with a Th2-associated expression pattern. J. Immunol. 160, 1411-1418.
130. Adema, G. J., Hartgers, F., Verstraten, R., de Vries, E., Marland, G., Menon, S., Foster, J., Xu, Y., Nooyen, P., McClanahan, T. (1997) A dendritic-cell-derived C-C chemokine that preferentially attracts naive T cells. Nature 387, 713-717.
131. Luzina, I. G., Papadimitriou, J. C., Anderson, R., Pochetuhen, K., Atamas, S. P. (2006) Induction of prolonged infiltration of T lymphocytes and transient T lymphocyte-dependent collagen deposition in mouse lungs following adenoviral gene transfer of CCL18. Arthritis. Rheum. 54, 2643-2655.
132. Pochetuhen, K., Luzina, I. G., Lockatell, V., Choi, J., Todd, N. W., Atamas, S. P. (2007) Complex regulation of pulmonary inflammation and fibrosis by CCL18. Am. J. Pathol. 171, 428-437.
133. Luzina, I. G., Todd, N. W., Nacu, N., Lockatell, V., Choi, J., Hummers, L. K., Atamas, S. P. (2009) Regulation of pulmonary inflammation and fibrosis through expression of integrins αVβ3 and αVβ5 on pulmonary T lymphocytes. Arthritis Rheum. 60, 1530-1539.
134. Atamas, S. P., Luzina, I. G., Choi, J., Tsymbalyuk, N., Carbonetti, N. H., Singh, I. S., Trojanowska, M., Jimenez, S. A., White, B. (2003) Pulmonary and activation-regulated chemokine stimulates collagen production in lung fibroblasts. Am. J. Respir. Cell Mol. Biol. 29, 743-749.
135. Atamas, S. P., Luzina, I. G., Ingels, J., Choi, J., Wong, W. K., Furst, D. E., Clements, P. J., Postlethwaite, A. E. (2010) Stimulation with type I collagen induces changes in gene expression in peripheral blood mononuclear cells from patients with diffuse cutaneous systemic sclerosis (scleroderma). Clin. Exp. Immunol. 161, 426-435.
136. Atamas, S. P., White, B. (2003) Cytokine regulation of pulmonary fibrosis in scleroderma. Cytokine Growth Factor Rev. 14, 537-550.
137. Luzina, I. G., Atamas, S. P., Wise, R., Wigley, F. M., Choi, J., Xiao, H. Q., White, B. (2003) Occurrence of an activated, profibrotic pattern of gene expression in lung CD8+ T cells from scleroderma patients. Arthritis Rheum. 48, 2262-2274.
138. Luzina, I. G., Atamas, S. P., Wise, R., Wigley, F. M., Xiao, H. Q., White, B. (2002) Gene expression in bronchoalveolar lavage cells from scleroderma patients. Am. J. Respir. Cell Mol. Biol. 26, 549-557.
139. Luzina, I. G., Tsymbalyuk, N., Choi, J., Hasday, J. D., Atamas, S. P. (2006) CCL18-stimulated upregulation of collagen production in lung fibroblasts requires Sp1 signaling and basal Smad3 activity. J. Cell. Physiol. 206, 221-228.
140. Pardo, A., Smith, K. M., Abrams, J., Coffman, R., Bustos, M., McClanahan, T. K., Grein, J., Murphy, E. E., Zlotnik, A., Selman, M. (2001) CCL18/DC-CK-1/PARC up-regulation in hypersensitivity pneumonitis. J. Leukoc. Biol. 70, 610-616.
141. Prasse, A., Pechkovsky, D. V., Toews, G. B., Jungraithmayr, W., Kollert, F., Goldmann, T., Vollmer, E., Muller-Quernheim, J., Zissel, G. (2006) A vicious circle of alveolar macrophages and fibroblasts perpetuates pulmonary fibrosis via CCL18. Am. J. Respir. Crit. Care Med. 173, 781-792.
142. de Nadai, P., Charbonnier, A. S., Chenivesse, C., Senechal, S., Fournier, C., Gilet, J., Vorng, H., Chang, Y., Gosset, P., Wallaert, B. (2006) Involvement of CCL18 in allergic asthma. J. Immunol. 176, 6286-6293.
143. Mrazek, F., Sekerova, V., Drabek, J., Kolek, V., du Bois, R. M., Petrek, M. (2002) Expression of the chemokine PARC mRNA in bronchoalveolar cells of patients with sarcoidosis. Immunol. Lett. 84, 17-22.
144. Atamas, S. P., Luzina, I. G., Dai, H., Wilt, S. G., White, B. (2002) Synergy between CD40 ligation and IL-4 on fibroblast proliferation involves IL-4 receptor signaling. J. Immunol. 168, 1139-1145.
145. Luzina, I. G., Todd, N. W., Iacono, A. T., Atamas, S. P. (2008) Roles of T lymphocytes in pulmonary fibrosis. J. Leukoc. Biol. 83, 237-244.
146. Mantovani, A., Sica, A., Sozzani, S., Allavena, P., Vecchi, A., Locati, M. (2004) The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 25, 677-686.
147. Martinez, F. O., Gordon, S., Locati, M., Mantovani, A. (2006) Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J. Immunol. 177, 7303-7311.
148. Anthony, R. M., Urban, J. F., Alem, F., Hamed, H. A., Rozo, C. T., Boucher, J-L., Van Rooijen, N., Gause, W. C. (2006) Memory TH2 cells induce alternatively activated macrophages to mediate protection against nematode parasites. Nat. Med. 12, 955-960.
149. Zhao, A., Urban J. F., Jr., Anthony, R. M., Sun, R., Stiltz, J., van Rooijen, N., Wynn, T. A., Gause, W. C., Shea-Donohue, T. (2008) Th2 cytokine-induced alterations in intestinal smooth muscle function depend on alternatively activated macrophages. Gastroenterology 135, 217-225. e211.
150. Bowcutt, R., Bell, L. V., Little, M., Wilson, J., Booth, C., Murray, P. J., Else, K. J., Cruickshank, S. M. (2011) Arginase-1-expressing macrophages are dispensable for resistance to infection with the gastrointestinal helminth Trichuris muris. Parasite Immunol. 33, 411-420.
151. Herbert, D. B. R., Orekov, T., Roloson, A., Ilies, M., Perkins, C., O'Brien, W., Cederbaum, S., Christianson, D. W., Zimmermann, N., Rothenberg, M. E. (2010) Arginase I suppresses IL-12/IL-23p40-driven intestinal inflammation during acute schistosomiasis. J. Immunol. 184, 6438-6446.
152. El Kasmi, K. C., Qualls, J. E., Pesce, J. T., Smith, A. M., Thompson, R. W., Henao-Tamayo, M., Basaraba, R. J., Konig, T., Schleicher, U., Koo, M-S. (2008) Toll-like receptor-induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogens. Nat. Immunol. 9, 1399-1406.
153. Butcher, B. A., Fox, B. A., Rommereim, L. M., Kim, S. G., Maurer, K. J., Yarovinsky, F., Herbert, D. B. R., Bzik, D. J., Denkers, E. Y. (2011) Toxoplasma gondii rhoptry kinase ROP16 activates STAT3 and STAT6 resulting in cytokine inhibition and arginase-1-dependent growth control. PLoS Pathog. 7, e1002236.
154. Yamamoto, M., Standley, D. M., Takashima, S., Saiga, H., Okuyama, M., Kayama, H., Kubo, E., Ito, H., Takaura, M., Matsuda, T. (2009) A single polymorphic amino acid on Toxoplasma gondii kinase ROP16 determines the direct and strain-specific activation of Stat3. J. Exp. Med. 206, 2747-2760.
155. Van den Bossche, J., Malissen, B., Mantovani, A., De Baetselier, P., Van Ginderachter, J. A. (2012) Regulation and function of the E-cadherin/ catenin complex in cells of the monocyte-macrophage lineage and DCs. Blood 119, 1623-1633.
156. Van den Bossche, J., Laoui, D., Morias, Y., Movahedi, K., Raes, G., De Baetselier, P., Van Ginderachter, J. A. (2012) Claudin-1, claudin-2 and claudin-11 genes differentially associate with distinct types of anti-inflammatory macrophages in vitro and with parasite-and tumor-elicited macrophages in vivo. Scand. J. Immunol. 75, 588-598.
157. Agarwal, R., Mori, Y., Cheng, Y., Jin, Z., Olaru, A. V., Hamilton, J. P., David, S., Selaru, F. M., Yang, J., Abraham, J. M. (2009) Silencing of claudin-11 is associated with increased invasiveness of gastric cancer cells. PLoS ONE 4, e8002.
158. Menzies, F. M., Henriquez, F. L., Alexander, J., Roberts, C. W. (2011) Selective inhibition and augmentation of alternative macrophage activation by progesterone. Immunology 134, 281-291.
159. Varin, A., Mukhopadhyay, S., Herbein, G., Gordon, S. (2010) Alternative activation of macrophages by IL-4 impairs phagocytosis of pathogens but potentiates microbial-induced signalling and cytokine secretion. Blood 115, 353-362.
160. Hunter, M. M., Wang, A., Parhar, K. S., Johnston, M. J. G., Van Rooijen, N., Beck, P. L., McKay, D. M. (2010) In vitro-derived alternatively activated macrophages reduce colonic inflammation in mice. Gastroenterology 138, 1395-1405.
161. Rizzo, A., Monteleone, I., Fina, D., Stolfi, C., Caruso, R., Fantini, M. C., Franzè E, Schwendener, R., Pallone, F., Monteleone, G. (2012) Inhibition of colitis by IL-25 associates with induction of alternatively activated macrophages. Inflamm. Bowel Dis. 18, 449-459.
162. Weisser, S. B., Brugger, H. K., Voglmaier, N. S., McLarren, K. W., van Rooijen, N., Sly, L. M. (2011) SHIP-deficient, alternatively activated macrophages protect mice during DSS-induced colitis. J. Leukoc. Biol. 90, 483-492.
163. Weng, M., Huntley, D., Huang I-F, Foye-Jackson, O., Wang, L., Sarkissian, A., Zhou, Q., Walker, W. A., Cherayil, B. J., Shi, H. N. (2007) Alternatively activated macrophages in intestinal helminth infection: effects on concurrent bacterial colitis. J. Immunol. 179, 4721-4731.
164. Chen, C-C., Louie, S., McCormick, B., Walker, W. A., Shi, H. N. (2005) Concurrent infection with an intestinal helminth parasite impairs host resistance to enteric Citrobacter rodentium and enhances Citrobacter-induced colitis in mice. Infect. Immun. 73, 5468-5481.
165. Urban J. F., Jr., Steenhard, N. R., Solano-Aguilar, G. I., Dawson, H. D., Iweala, O. I., Nagler, C. R., Noland, G. S., Kumar, N., Anthony, R. M., Shea-Donohue, T. (2007) Infection with parasitic nematodes confounds vaccination efficacy. Vet. Parasitol. 148, 14-20.
166. Schroedl, C., Kalhan, R. (2012) Incidence, treatment options, and outcomes of lung cancer in patients with chronic obstructive pulmonary disease. Curr. Opin. Pulm. Med. 18, 131-137.
167. Terzíc, J., Grivennikov, S., Karin, E., Karin, M. (2010) Inflammation and colon cancer. Gastroenterology 138, 2101-2114. e2105.
168. Schmieder, A., Michel, J., Schönhaar, K., Goerdt, S., Schledzewski, K. (2012) Differentiation and gene expression profile of tumor-associated macrophages. Semin. Cancer Biol. 22, 289-297.
169. Wang, B., Li, Q., Qin, L., Zhao, S., Wang, J., Chen, X. (2011) Transition of tumor-associated macrophages from MHC class II(hi) to MHC class II(low) mediates tumor progression in mice. BMC Immunol. 12, 43.
170. Li, B. H., Xu, S. B., Li, F., Zou, X. G., Saimaiti, A., Simayi, D., Wang, Y. H., Zhang, Y., Yuan, J., Zhang, W. J. (2012) Stat6 activity-related Th2 cytokine profile and tumor growth advantage of human colorectal cancer cells in vitro and in vivo. Cell. Signal. 24, 718-725.
171. Chawla, A., Nguyen, K. D., Goh, Y. P. S. (2011) Macrophage-mediated inflammation in metabolic disease. Nat. Rev. Immunol. 11, 738-749.
172. Olefsky, J. M., Glass, C. K. (2010) Macrophages, inflammation, and insulin resistance. Ann. Rev. Physiol. 72, 219-246.
173. Stienstra, R., Duval, C., Keshtkar, S., van der Laak, J., Kersten, S., Müller, M. (2008) Peroxisome proliferator-activated receptor α activation promotes infiltration of alternatively activated macrophages into adipose tissue. J. Biol. Chem. 283, 22620-22627.
174. Odegaard, J. I., Ricardo-Gonzalez, R. R., Goforth, M. H., Morel, C. R., Subramanian, V., Mukundan, L., Eagle, A. R., Vats, D., Brombacher, F., Ferrante, A. W. (2007) Macrophage-specific PPARβ controls alternative activation and improves insulin resistance. Nature 447, 1116-1120.
175. Fischer-Posovszky, P., Wang, Q. A., Asterholm, I. W., Rutkowski, J. M., Scherer, P. E. (2011) Targeted deletion of adipocytes by apoptosis leads to adipose tissue recruitment of alternatively activated M2 macrophages. Endocrinology 152, 3074-3081.
176. Kawanishi, N., Yano, H., Yokogawa, Y., Suzuki, K. (2010) Exercise training inhibits inflammation in adipose tissue via both suppression of macrophage infiltration and acceleration of phenotypic switching from M1 to M2 macrophages in high-fat-diet-induced obese mice. Exerc. Immunol. Rev. 16, 105-118.
177. Xia, S., Sha, H., Yang, L., Ji, Y., Ostrand-Rosenberg, S., Qi, L. (2011) Gr-1+ CD11b+ myeloid-derived suppressor cells suppress inflammation and promote insulin sensitivity in obesity. J. Biol. Chem. 286, 23591-23599.
178. Wenzel, S., Wilbraham, D., Fuller, R., Getz, E. B., Longphre, M. (2007) Effect of an interleukin-4 variant on late phase asthmatic response to allergen challenge in asthmatic patients: results of two phase 2a studies. Lancet 370, 1422-1431.